In this issue:
- Continuation of bridging therapy steroids in RA
- X-rays for diagnosing CPPD
- Rheumatology care continuity in early RA and ED visits/hospitalisations
- Prednisone for alleviating methotrexate side effects in RA
- Opportunistic infections in autoimmune inflammatory rheumatic diseases
- Biologic responses in RA with antidrug antibodies
- Adalimumab vs. tofacitinib for RA
- Erosive hand OA: four common variants associated with larger effect
- Autoimmune disorders in the UK
- Long-term upadacitinib for RA
Please login below to download this issue (PDF)